More on NEPH
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $4.38 |
|
|||
| Open | $4.26 | ||||
| 52 Wk High | $0.60 | ||||
| 52 Wk Low | $0.20 | ||||
| Day High | $4.26 | ||||
| Day Low | $4.26 | ||||
| P/E | N/A | ||||
| EPS | $-0.27 | ||||
| Volume | 5,162 | ||||
- Form SCHEDULE 13D/A NEPHROS INC Filed by: WEXFORD CAPITAL LP
- Form SCHEDULE 13G NEPHROS INC Filed by: DAVIDSON CHARLES E
- Form 4 NEPHROS INC For: Sep 14 Filed by: DAVIDSON CHARLES E
- Form 4 NEPHROS INC For: Sep 14 Filed by: Amron Arthur H
- Form 4 NEPHROS INC For: Aug 18 Filed by: Wexford GP LLC
- Benchmark Reiterates Speculative Buy Rating on Nephros (NEPH) Following Strong Q2 Results
- Form 4 NEPHROS INC For: Aug 12 Filed by: Amron Arthur H
- Form 10-Q NEPHROS INC For: Jun 30
- Nephros Announces Strong Financial Results for Quarter Ended June 30, 2026
- Form 8-K NEPHROS INC For: Aug 06
Entities mentioned with NEPH
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- FDA | View Related Stories »
- Dividend | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Maxim Group | View Related Stories »
- Show More...
